Lonnel Coats insider trades

Open-market stock purchases and sales by Lonnel Coats, Director at Mineralys Therapeutics, Inc, from SEC Form 4 filings since Jul 7, 2014.

Track record: 28% of 36 scored buys are up 5% or more since purchase, averaging -47%.

Recent trades

DateStockTradeValue
Oct 19, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Oct 19, 2026MLYS Mineralys Therapeutics, IncBought (not open market)—
Jun 9, 2026RLAY Relay Therapeutics, IncBought (not open market)—
Nov 4, 2025RLAY Relay Therapeutics, IncBought (not open market)—

Companies traded

  • MLYS Mineralys Therapeutics, Inc: other filings, last Oct 19, 2026
  • RLAY Relay Therapeutics, Inc: other filings, last Jun 9, 2026
  • VERV Verve Therapeutics, Inc: other filings, last Jul 25, 2025
  • BPMC Blueprint Medicines Corp: 7 sales, last Jul 17, 2025
  • LXRX Lexicon Pharmaceuticals, Inc: 36 buys, last Feb 28, 2024

Get free alerts when Lonnel Coats files a new trade →